BNTX insider transactions
BioNTech SE (BNTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for BNTX
- Chief Executive Officer Sahin Ugur sold $6,239,071 worth of Ordinary Shares (64,000 units at $97.49) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 489,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $4,721,976 worth of Ordinary Shares (49,000 units at $96.37) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 553,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $8,439,336 worth of Ordinary Shares (86,000 units at $98.13) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 602,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $1,974,287 worth of Ordinary Shares (20,500 units at $96.31) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 688,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $7,190,663 worth of Ordinary Shares (73,000 units at $98.50) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 708,709 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $7,889,055 worth of Ordinary Shares (76,500 units at $103.12) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 781,709 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Low-Friedrich Iris Katharina3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Schaffert Susanne3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Zapata Gomez Ramon4 - BioNTech SE (0001776985) (Issuer)
- SEC Form 4 filed by Officer Ryan James Timothy Patrick4 - BioNTech SE (0001776985) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Poetting Sierk4 - BioNTech SE (0001776985) (Issuer)
- SEC Form 4 filed by Chief People Officer Jimenez Kylie4 - BioNTech SE (0001776985) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Hanekamp Annemarie4 - BioNTech SE (0001776985) (Issuer)
- Chief Operating Officer Poetting Sierk sold $5,527,960 worth of Ordinary Shares (50,000 units at $110.56) (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Amendment: SEC Form 3 filed by new insider Sahin Ugur3/A - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Blackwood Nicola Claire3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Morawietz Anja3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Staudigl Rudolf3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Sahin Ugur3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Zapata Gomez Ramon3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Ryan James Timothy Patrick3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Jimenez Kylie3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Jeggle Helmut Wolfgang3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Poetting Sierk3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Motschmann Michael3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Wandschneider Ulrich3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Tureci Ozlem3 - BioNTech SE (0001776985) (Issuer)
- SEC Form 3 filed by new insider Hanekamp Annemarie3 - BioNTech SE (0001776985) (Issuer)